Patent 6630507: Why You Should Know About This Number

Patent 6630507

6630507 may look like some random jumble of numbers. Maybe even a phone number, but it is much more than that. Here is why you need to know about Patent 6630507.

Patent 6630507 holds a lot of weight and represents the hypocrisy of our nation’s government for that last few decades. This number is a US patent that was filed initially by scientists for the National Institutes of Health (NIH) in 1999. It was granted to the Department of Health and Human Services in 2003.

The patent states that cannabinoids have antioxidant and neuroprotective properties that are sufficient in potentially treating a multitude of illnesses and diseases. Patent 6630507 also references more than 10 other cannabis related patents dating back to the days of world war II. Beyond these patents, cannabis was utilized for a plethora of medical purposes for thousands of years around the world. Then it was suddenly criminalized. The patent doesn’t cover the entire cannabis plant. Only the non psychoactive cannabinoids, such as cannabidoil (CBD). In 2011, the NIH granted New York-based Kannalife Sciences Inc. an exclusive license to utilize part of the technology outlined in the patent to develop cannabinoid based drugs.

So the overarching question here is how much longer are we going to contradict ourselves?

Cannabis is still considered a schedule 1 drug. Despite the fact, that in order to be schedule 1, a drug must have no medical value, which cannabis clearly does. Other schedule 1 drugs are LSD, ecstasy, and heroin. Some notable schedule 2 drugs are cocaine, vicodin, meth, adderall, ritalin, and fentanyl. Yes, the same fentanyl that claimed the lives of Mac Miller, Prince, and Tom Petty. So how is it that all of these other drugs which are known to be lethal are considered less dangerous than a natural plant that has never killed anyone? Either our DEA and government are dangerously miseducated or there have been multiple forces shoving cannabis into the shadows.

This patent doesn’t change the Controlled Substances Act. However, Patent 6630507 does expire on April 21st 2019, after which anyone would be able to develop drugs based on these cannabinoids depending on FDA approval. Coincidentally, the day after 4/20 will be another huge day for cannabis in 2019.

Patent 6630507 proves that the government is aware that cannabis has some medicinal properties. This goes against its drug scheduling guidelines. The expiration of this patent will lead our National government to reschedule cannabis in the near future and put an end to the hypocrisy. Come back to The Happy Campers for all your latest cannabis news and findings.

Leave a Reply